Stocks News

LAST PRICE
486.2750
TODAY'S CHANGE (%)
Trending Up2.5950 (0.5365%)

Bid / Lots
486.0900/ 2
Ask / Lots
486.5000/ 1
Open / Previous Close
481.8000 / 483.6800
Day Range
Low 475.9700
High 486.9700
52 Week Range
Low 372.5000
High 583.3900
Volume
295,554
below average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

May 2, 2024
- DJ IDEXX Labs Is Maintained at Overweight by Barclays, from 2:00PM ET on Thursday May 02, 2024 by Dow Jones
  2:00PM ET on Thursday May 02, 2024 by Dow Jones
  Companies Mentioned: IDXX
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/IDXX/analyst-ratings
  
  (END) Dow Jones Newswires
  
  May 02, 2024 14:00 ET (18:00 GMT)
- Goldman Sachs Adjusts Price Target on IDEXX Laboratories to $600 From $675, from 10:31AM ET on Thursday May 02, 2024 by MT Newswires
  10:31AM ET on Thursday May 02, 2024 by MT Newswires
  Companies Mentioned: IDXX
  10:31 AM EDT, 05/02/2024 (MT Newswires) -- IDEXX Laboratories (IDXX) has an average outperform rating and a price target range of $400 to $653, according to analysts polled by Capital IQ. (MT Newswires covers equity, commodity and economic research ...
- BNP Paribas Adjusts Price Target on IDEXX Laboratories to $641 From $653, from 10:30AM ET on Thursday May 02, 2024 by MT Newswires
  10:30AM ET on Thursday May 02, 2024 by MT Newswires
  Companies Mentioned: IDXX
  10:30 AM EDT, 05/02/2024 (MT Newswires) -- IDEXX Laboratories (IDXX) has an average rating of outperform and price targets ranging from $400 to $653, according to analysts polled by Capital IQ. (MT Newswires covers equity, commodity and economic res...
- Stifel Adjusts Price Target on IDEXX Laboratories to $520 From $570, from 10:20AM ET on Thursday May 02, 2024 by MT Newswires
  10:20AM ET on Thursday May 02, 2024 by MT Newswires
  Companies Mentioned: IDXX
  10:20 AM EDT, 05/02/2024 (MT Newswires) -- IDEXX Laboratories (IDXX) has an average outperform rating and price target range of $400 to $653, according to analysts polled by Capital IQ. (MT Newswires covers equity, commodity and economic research fr...
- Barclays Adjusts Price Target on IDEXX Laboratories to $570 From $655, from 9:46AM ET on Thursday May 02, 2024 by MT Newswires
  9:46AM ET on Thursday May 02, 2024 by MT Newswires
  Companies Mentioned: IDXX
  09:46 AM EDT, 05/02/2024 (MT Newswires) -- IDEXX Laboratories (IDXX) has an average outperform rating and price target range of $400 to $653, according to analysts polled by Capital IQ. (MT Newswires covers equity, commodity and economic research fr...

May 1, 2024
- HSBC Adjusts Align Technology Price Target to $370 From $350, from 8:29AM ET on Wednesday May 01, 2024 by MT Newswires
  8:29AM ET on Wednesday May 01, 2024 by MT Newswires
  Companies Mentioned: ALGN
Apr 30, 2024
- West to Participate in Upcoming Investor Conference, from 6:00AM ET on Tuesday Apr 30, 2024 by PR Newswire
  6:00AM ET on Tuesday Apr 30, 2024 by PR Newswire
  Companies Mentioned: WST
Apr 26, 2024
- UBS Adjusts West Pharmaceutical Services Price Target to $390 From $375, Maintains Neutral Rating, from 11:34AM ET on Friday Apr 26, 2024 by MT Newswires
  11:34AM ET on Friday Apr 26, 2024 by MT Newswires
  Companies Mentioned: WST
- Morgan Stanley Adjusts DexCom's Price Target to $132 From $122, from 11:08AM ET on Friday Apr 26, 2024 by MT Newswires
  11:08AM ET on Friday Apr 26, 2024 by MT Newswires
  Companies Mentioned: DXCM
- Jefferies Adjusts Price Target on West Pharmaceutical Services to $426 From $423, from 10:56AM ET on Friday Apr 26, 2024 by MT Newswires
  10:56AM ET on Friday Apr 26, 2024 by MT Newswires
  Companies Mentioned: WST
- Canaccord Genuity Adjusts Price Target on DexCom to $145 From $144, from 10:53AM ET on Friday Apr 26, 2024 by MT Newswires
  10:53AM ET on Friday Apr 26, 2024 by MT Newswires
  Companies Mentioned: DXCM
- Raymond James Adjusts DexCom Price Target to $160 From $151, from 10:25AM ET on Friday Apr 26, 2024 by MT Newswires
  10:25AM ET on Friday Apr 26, 2024 by MT Newswires
  Companies Mentioned: DXCM
- Align Technology to Buy Back $150 Million in Shares, from 10:05AM ET on Friday Apr 26, 2024 by MT Newswires
  10:05AM ET on Friday Apr 26, 2024 by MT Newswires
  Companies Mentioned: ALGN
- Align Technology Announces $150 Million Open Market Repurchase, from 8:30AM ET on Friday Apr 26, 2024 by Business Wire
  8:30AM ET on Friday Apr 26, 2024 by Business Wire
  Companies Mentioned: ALGN
Apr 25, 2024
- DexCom Q1 Non-GAAP Earnings, Revenue Rise; 2024 Revenue Guidance Gains; Shares Fall After Hours, from 4:43PM ET on Thursday Apr 25, 2024 by MT Newswires
  4:43PM ET on Thursday Apr 25, 2024 by MT Newswires
  Companies Mentioned: DXCM

IDEXX Laboratories Inc
NASDAQ:IDXXUnited States

Search Criteria

May 2, 2024

DJ IDEXX Labs Is Maintained at Overweight by Barclays, from 2:00PM ET on Thursday May 02, 2024 by Dow Jones

Goldman Sachs Adjusts Price Target on IDEXX Laboratories to $600 From $675, from 10:31AM ET on Thursday May 02, 2024 by MT Newswires

BNP Paribas Adjusts Price Target on IDEXX Laboratories to $641 From $653, from 10:30AM ET on Thursday May 02, 2024 by MT Newswires

Stifel Adjusts Price Target on IDEXX Laboratories to $520 From $570, from 10:20AM ET on Thursday May 02, 2024 by MT Newswires

Barclays Adjusts Price Target on IDEXX Laboratories to $570 From $655, from 9:46AM ET on Thursday May 02, 2024 by MT Newswires

Peers Headlines

May 1, 2024

HSBC Adjusts Align Technology Price Target to $370 From $350, from 8:29AM ET on Wednesday May 01, 2024 by MT Newswires

Apr 30, 2024

West to Participate in Upcoming Investor Conference, from 6:00AM ET on Tuesday Apr 30, 2024 by PR Newswire

Apr 26, 2024

UBS Adjusts West Pharmaceutical Services Price Target to $390 From $375, Maintains Neutral Rating, from 11:34AM ET on Friday Apr 26, 2024 by MT Newswires

Morgan Stanley Adjusts DexCom's Price Target to $132 From $122, from 11:08AM ET on Friday Apr 26, 2024 by MT Newswires

Jefferies Adjusts Price Target on West Pharmaceutical Services to $426 From $423, from 10:56AM ET on Friday Apr 26, 2024 by MT Newswires

Canaccord Genuity Adjusts Price Target on DexCom to $145 From $144, from 10:53AM ET on Friday Apr 26, 2024 by MT Newswires

Raymond James Adjusts DexCom Price Target to $160 From $151, from 10:25AM ET on Friday Apr 26, 2024 by MT Newswires

Align Technology to Buy Back $150 Million in Shares, from 10:05AM ET on Friday Apr 26, 2024 by MT Newswires

Align Technology Announces $150 Million Open Market Repurchase, from 8:30AM ET on Friday Apr 26, 2024 by Business Wire

Apr 25, 2024

DexCom Q1 Non-GAAP Earnings, Revenue Rise; 2024 Revenue Guidance Gains; Shares Fall After Hours, from 4:43PM ET on Thursday Apr 25, 2024 by MT Newswires